Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02834767 · ClinicalTrials.gov registry record · NA
Genioglossus Muscle Training for Snoring and Obstructive Sleep Apnea
A NA study, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 23
- Enrollment target
NCT02834767: Completed NA study, sponsored by University of Florida.
NCT02834767 is a NA study that has completed, run by University of Florida. The registered enrollment target is 23 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02834767, a NA study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
Study Summary
Obstructive sleep apnea (OSA) carries serious health consequences for patients. Evidence exists that some behavioral (e.g. exercise based) therapies may assist in lessening the severity of this disorder. The proposed investigation will examine the effects of eight weeks of genioglossus muscle strength training on measures of snoring and OSA severity as well as genioglossus protrusive muscle strength.
Primary Outcome
Maximum pressure generated (in Newtons) during tongue protrusion
Interventions
- DEVICE Genioglossis Strength Trainer
- DEVICE Placebo Genioglossis Strength Trainer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2016-10 |
| Est. Completion | 2019-05-04 |
| Phase | NA |
What the finished NCT02834767 record still lists
NCT02834767 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Genioglossis Strength Trainer is the first listed.
NCT02834767 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02834767 about?
NCT02834767 is a clinical study titled "Genioglossus Muscle Training for Snoring and Obstructive Sleep Apnea". Obstructive sleep apnea (OSA) carries serious health consequences for patients. Evidence exists that some behavioral (e.g. exercise based) therapies may assist in lessening the severity of this disorder. The proposed investigation will examine the effects of eight weeks of genioglossus muscle streng...
What is the current status of trial NCT02834767?
This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2016-10. Estimated completion is 2019-05-04.
What interventions are being tested in trial NCT02834767?
The interventions under investigation include: Genioglossis Strength Trainer (DEVICE), Placebo Genioglossis Strength Trainer (DEVICE).
Who is sponsoring clinical trial NCT02834767?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02834767's enrollment target sits among peer trials
23 1755th of 2000 higher than 245 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia